Apellis Pharmaceuticals Vs. Transcat Industry Stock Comparison

Sell

24

APLS
Apellis Pharmaceuticals

Last Price:

$17.89

Seasonality Move:

-16.64%

Buy

63

TRNS
Transcat

Last Price:

$87.53

Seasonality Move:

4.11%

Sell

24

Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

The current Apellis Pharmaceuticals [APLS] share price is $17.42. The Score for APLS is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

63

Transcat (TRNS) is a Buy

Is Transcat a Buy, Sell or Hold?

The current Transcat [TRNS] share price is $89.88. The Score for TRNS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
TRNS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

The Apellis Pharmaceuticals share price today is $17.42

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

TRNS Stock Price Chart

What is Transcat's stock price today?

The Transcat share price today is $89.88

The current trend is moderately bullish and TRNS is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.19	Sell
Relative Strength Index (14 RSI):	43.43	Sell
Chaikin Money Flow:	-1333141	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(17.61 - 19.09)	Sell
Bollinger Bands (100):	(17.18 - 24.74)	Sell

TRNS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.51	Buy
Relative Strength Index (14 RSI):	65.92	Buy
Chaikin Money Flow:	21495	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	( - )	Buy
Bollinger Bands (100):	( - )	Buy

APLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	17.86	Sell
20-day SMA:	18.31	Sell
50-day SMA:	18.14	Sell
200-day SMA:	25.77	Sell
8-day EMA:	17.85	Sell
20-day EMA:	18.05	Sell
50-day EMA:	18.79	Sell
200-day EMA:	26.11	Sell

TRNS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	85.85	Buy
20-day SMA:	81.57	Buy
50-day SMA:	82.83	Buy
200-day SMA:	94.68	Sell
8-day EMA:	86.24	Buy
20-day EMA:	83.96	Buy
50-day EMA:	82.84	Buy
200-day EMA:	91.27	Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.24 per share, and an increase next year of $0.74 per share.

Transcat Earnings Growth & TRNS Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.11 per share.

Apellis Pharmaceuticals Technical Analysis

	Jun 23	Jun 24	Jun 25	Jun 26	Jun 27	Jun 30	Jul 1	Jul 2	Jul 3	Jul 7
	Jun							Jul
	23	24	25	26	27	30	01	02	03	07
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Transcat Technical Analysis

	Jun 23	Jun 24	Jun 25	Jun 26	Jun 27	Jun 30	Jul 1	Jul 2	Jul 3	Jul 7
	Jun							Jul
	23	24	25	26	27	30	01	02	03	07
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):